Lexaria Bioscience
LEXX | NASDAQ
$4.41
-$0.03 (-0.68%)
At close: Nov 16, 2026, 4:00 PM ET
$4.11
-$0.30 (-6.80%)
After-hours:
Nov 16, 2026, 4:23 PM ET
-0.68%
(1D)No price chart data available for 1D timeframe.
Rating
29
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #834/1021 (Top 82%)
Key Statistics
Market Data
Market Cap $7.29M
1D Range
4.00 4.48
52W Range
2.60 20.10
Valuation (TTM)
PE -0.83
PB 1.54
EV/EBITDA -0.49
Valuation (NTM)
Forward PE N/A
Forward PEG -0.06
Price Target $1.50
Cash Flow
FCF Yield -103.3%
SBC Adj. FCF Yield -108.3%
SBC Impact -4.9%
Margins
Gross Margin 100.0%
Operating Margin -3973.2%
FCF Margin -3880.1%
Growth (CAGR)
Revenue 3Y | 5Y -14.2% |
-25.1%
Dil EPS 3Y | 5Y 8.6% |
28.4%
FCF 3Y | 5Y -17.9% |
-14.5%
Returns
ROA -161.7%
ROE -160.7%
ROIC -174.0%
Financial Health
Net Cash
$3.62M
Current Ratio 10.60
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of act...
Sector Healthcare
Industry Biotechnology
Employees 7
IPO Date Jan 12, 2021
Website www.lexariabioscience.com
Fiscal Year September - August
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$1.50
Downside
-65.99%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove LEXX